The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Updated Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection have been updated, March 24, 2005. Please note that the Appendix, Characteristics of Available Antiretroviral Drugs, has been extensively modified to include up-to-date drug information, including updated information about pediatric dosing and new drug formulations. The updated Appendix also includes a matrix based on Table 16 in the Adult Guidelines (adverse drug reactions) and three matrices based on Tables 19-21 in the Adult Guidelines (drug interactions between antiretrovirals and other drugs).
The Pediatric Guidelines are developed by the Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, which reviews new data on an ongoing basis and provides regular updates to the guidelines.
The updated guidelines document is available in the Pediatric Guidelines section of the Guidelines page on the AIDSinfo Web site.
The AIDSinfo website (AIDSinfo@nih.gov) is also a valuable source of other information related to HIV/AIDS, including other treatment and prevention guidelines, downloadable databases for PDAs (Personal Digital Assistants), and HIV/AIDS-related clinical trials information.
HIV/AIDS Program Director
Office of Special Health Issues
Food and Drug Administration